Drug Approvals
🌏 NMPA Page 6NMPA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 61–72 of 97 articles
Kelun-Biotech's ASCO 2026 Presentation: Key Insights on NSCLC
AbbVie and GSK's Rise in Patient Reputation: Insights for Pharma
Clinical Trials Day 2026: Research Rising in Oncology
Merck's TroFuse-005 Trial Results: Implications for Investors and Pharma Teams
Ildong Pharmaceutical Stock: Earnings and Pipeline Insights
Kelun and Merck's Lung Cancer Combo Shows Promise in China
Kelun-Biotech Secures Investigational New Drug Approval for SKB118
Merck’s Billion-Dollar Bet on TROP2: Regulatory Updates and Implications
ZTE Partners with China's National Clinical Research Center for Clinical Trials
Novartis Strengthens Prostate Cancer Treatment with Pluvicto
Takeda's $885M Verdict: Implications for Pharma Business Strategies
Asia-Pacific Regulatory Updates: TGA Guidance on Compounded Medicines